Antimicrobial Stewardship (AMS)
AMS is a term used to describe a variety of clinical interventions where the sole purpose is to improve and measure the appropriate use of antimicrobial agents (e.g. antibiotics, antifungals, antivirals). Bacterial resistance and adverse effects from antimicrobials are growing concerns in the general public and health care systems nation-wide. We are losing our antimicrobials to multi-drug resistant bugs.
Not only do we need to change prescribing practices to minimize unnecessary or excessive antimicrobial exposure for the sake of our patients, we need to be responsible for our own health and that of our families in the future (when antibiotics might be needed). We also want to reduce adverse events such as C. difficile infection.
Resources
NH AMS program goal
To improve patient care related to antimicrobial use in all NH facilities through collaboration with healthcare providers in order to:
- Successfully treat infections
- Reduce inappropriate antimicrobial use
- Minimize toxicities and adverse events
- Limit selection of antimicrobial resistant strains
NH AMS program background
Northern Health’s Antimicrobial Stewardship (AMS) Program development began in November 2014. Research was done to find out what was happening within BC as well as across Canada with regards to the development and operations of an AMS program within the acute care setting. A case was built based on the standards set by Accreditation Canada and the structure of Northern Health. Resource allocation was granted in October 2015 for a full time pharmacist lead (the AMS program Coordinator), data analyst support and a 0.4 FTE equivalent Medical Co-lead position with shared interest between the AMS program and the Infection Prevention and Control (IPC) program.
In the beginning an AMS working group was established with interdisciplinary and regional representation to help guide and support the lead pharmacist in establishment of the framework for the AMS program. Now the AMS working group has become a permanent committee under the NH Medication Safety and Quality Committee and as the AMS Subcommittee. The position of Medical co-Lead for the AMS program and IPC was filled by our infectious disease expert Dr. Abu Hamour in March 2017. Plans for collaborative work with the co-leads will be commencing in quarter 1 of the 2017/18 FY.
The AMS program is fortunate to have the opportunity to collaborate with the Infection Prevention and Control Program lead by Regional Manager, Deanna Hembroff. Discussions between the co-leads have commenced and plans for staff education and quality improvement have begun. Readers will be able to find on the AMS page information relating to infection prevention reporting, accreditation, and online resources.
Contact us:
Alicia Rahier, BSc. Pharm. ACPR
NH AMS Program Coordinator
Email: alicia.rahier@northernhealth.ca
Phone: 250-612-2030
Dr. Abu Hamour, MBBS, MSc, DTM&H, MRCP(UK), CCST (UK), FRCP (Edin), FRCPC
Internal Medicine, Infectious Disease Specialist, AMS Medical Co-Lead
Email: abuobeida.hamour@northernhealth.ca
Phone: 250-563-8284
Fax: 250-563-8285
Deanna Hembroff
Regional Manager, Infection Prevention & Control Program
Email: deanna.hembroff@northernhealth.ca
Phone: 250-622-6247
- Clostridium difficile infection treatment for adult inpatients
- Adult sepsis
- Adult febrile neutropenia
- Community acquired pneumonia
- Initiation of aminoglycosides for adult inpatients
- Initiation of vancomycin for adult inpatients
- IV antimicrobial therapy for outpatients
- COPD acute exacerbation - Admission orders
- COPD acute exacerbation - 48 hours after admission
- COPD acute exacerbation - Discharge orders
- Oseltamivir for influenza outbreak declared by medical health officer
- Audit and feedback policy (PDF)
- Infectious diseases consultation for prolonged duration intravenous antimicrobials (PDF) (To view Northern Health resources, you must log in using your NH username and password)
- IV to PO conversion of antimicrobials (PDF)
- Outpatient parenteral therapy (PDF)
- Pharmacist managed monitoring and dosing of vancomycin and aminoglycosides (PDF)
Smart phone applications
(Formerly known as Spectrum)
NH specific guidelines and resources are now available through Firstline mobile health (formerly known as Spectrum). The application is free to use and available from the App store for IOS and android users. If you are new to using this application check out our How-to-Guide for a general overview in navigating this application.
Resources and tools
- Antibacterial dosing guidance from BC Children's Hospital
- NH antibiogram
- BC Children’s Hospital antimicrobial guidelines
If you have any questions about Firstline or other listed resources, please email Alicia Rahier or call 250-612-2030.
Online references
- Association for Medical Microbiology and Infectious Disease of Canada (Canadian)
- Bugs and drugs book (Canadian)
- BC Centre for Disease Control (Canadian)
- Centre for Disease Control (American)
- Infectious Disease Society of America (American)
- MyNH infection prevention and control page (to view this page you must log in using your NH username and password)
Education
The Antimicrobial Stewardship Program has two courses (Urinary Tract Infections and Pneumonia) available on the Learning Hub platform. Each course consists of 3 modules that should take approximately 20 to 30 minutes to complete.
The courses provide a general overview of the pathophysiology, common causative pathogens, signs/symptoms, as well as how and when to treat these conditions. Course content incorporates NH-specific information on antimicrobial susceptibilities as per the current NH antibiogram, and there are links to additional AMS resources as well.
Courses searchable as "NHA – AMS – Urinary Tract Infections" and "NHA – AMS – Pneumonia".
Annual reports
- 2022-2023 Annual report
- 2021-2022 Annual report
- 2020-2021 Annual report
- 2019-2020 Annual report
- 2018-2019 Annual report
- 2017-2018 Annual report
- 2016-2017 Annual report
Infection prevention and control reports
2017-2018
Annual reports
- 2019-2020 IP Annual report - in progress
- 2018-2019 IPC Annual report
- 2016-2017 IPC Annual report